After learning that pharma giant, Merck, has filed for a US patent for a blockchain-based system, GlobalData has been led to believe that the first applications of blockchain will be seen in the healthcare supply chain as an invaluable tool to combat counterfeit drugs.
Blockchain
Applications for blockchain within a healthcare setting have been explored by Merck since 2016, when Nishan Kulatilaka — associate director of product management and applied technology at the company — speculated that after financial services, healthcare could be the second largest industry to adopt the tech.